Circulatory and Respiratory Physiological Phenomena

21 trials 8 recruiting

Filter these 21 trials by phase, country and sponsor.

Open in Search →

The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending

2024-516279-34-00 Pulmonary Hypertension 6
Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a… Pending

2025-525153-39-00 Chronic thromboembolic pulmonary hypertension 5
High-dose Insulin Euglycemic Therapy in Non-Toxic Acute Cardiogenic Shock. An investigator initiated randomized open labeled pilot trial … Pending

2025-523858-13-01 Non-toxic acute cardiogenic shock 4
morPHinE clearance and glomerular filtration in the Drepanocytic in crisis in REAnimation. Recruiting

2024-511985-34-00 Evaluation of the CKD-Epi score to identify a glomerula 6 2026-03-05
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting

2024-517004-11-00 Chronic pulmonary aspergillosis 5 2024-10-22
Comparison of the effects of Belatacept and Anticalcineurins on endothelial function in kidney transplant patients - BELAFENDO Recruiting

2024-515577-10-00 Kidney transplant 6 2025-07-24
The use of sildenafil in patients with univentricular heart after Fontan operation - a pilot SINFON-POL study. Recruiting

2023-503913-31-01 Patients with functionally single ventricle (FSV - func 5 2025-06-27
STOP-IMH Recruiting

2024-517783-37-00 ST elevation myocardial infarction (STEMI) 6 2024-09-20
Evaluation of the hemodynamic tolerance of potassium canrenoate in brain-dead organ donors Recruiting

2024-513809-31-00 Brain-dead Organ Donors 4 2024-08-27
EXLIBRIS : “EXL-01 combined with nivolumab for advanced NSCLC refractory to immunotherapy” Recruiting

2023-505285-28-01 Patients (male or female) ≥18 years old with histologic 9 2024-07-16
EPI/HIS-trial Recruiting

2024-517017-33-00 No medical condition, it is a study in healthy voluntee 3 2023-04-04
Brentuximab Vedotin plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL Ended

2023-503384-41-00 Relapsed or refractory diffuse large B-cell lymphoma (D 5 2020-12-22
Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency (CAP… Ended

2023-504998-20-00 Metastatic Hormone-sensitive Prostate Cancer Characteri 5 2020-09-18
A global study to assess the effects of Osimertinib following chemoradiation in patients with Stage III unresectable non-small cell lung can… Ended

2022-500860-36-00 Histologically documented non-small cell lung cancer of 5 2018-09-19
Oral vs Intravenous Fluids – healthy volunteers Ended

2024-519656-85-00 Hemodynamic parameters is to be investigated -- compari 3 2025-03-18
A study to investigate VMX-C001 in healthy volunteers. Ended

2024-514339-87-00 To restore coagulation in patients taking DOACs who are 3 2024-08-14
Acetated Ringer´s solution in experimental hypovolemia Ended

2023-503946-30-00 Hypovolemia 6 2024-03-02
The Colder Fluids Study Ended

2023-506018-35-00 Hemodynamic parameters is to be investigated -- compari 3 2023-11-06
Plethysmography with acetylcholin and carbacholin – A clinical method study Ended

2023-503908-87-00 Vascular dysfunction 4 2023-06-02
Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve… Ended

2024-518041-16-00 healthy volunteers 6 2022-06-15
VIRTUOSE: Efficiency of sildenafil on the absolute claudication distance of peripheral arterial disease patients with intermittent claudicat… Ended

2024-516429-30-00 Peripheral arterial disease 5 2021-11-24